EBS

Emergent Bio
NYSE

实时行情|Nasdaq Last Sale

51.22
-6.12
-10.67%
已收盘, 16:56 03/27 EDT
开盘
55.05
昨收
57.34
最高
56.94
最低
51.00
成交量
48.85万
成交额
--
52周最高
71.19
52周最低
39.11
市值
26.63亿
市盈率(TTM)
49.84
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测EBS价格均价为71.83,最高价位75.00,最低价为67.00。

EPS

EBS 新闻

更多
  • 受疫情蔓延影响 丰田汽车2月产量大减14%
  • 新浪财经 · 26分钟前
  • LV母公司警告一季度营收或下降20%
  • 新浪财经 · 27分钟前
  • 消息称日本拟增发16万亿日元国债为刺激计划筹资
  • 新浪财经 · 46分钟前
  • 澳大利亚推出重磅工资补贴 股市创40年最大单日涨幅
  • 央视 · 1小时前

所属板块

制药
-0.40%
制药与医学研究
-0.87%

热门股票

代码
价格
涨跌幅

EBS 简况

Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. It operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride).
展开

微牛提供Emergent Biosolutions Inc(NYSE-EBS)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的EBS股票新闻,以帮助您做出投资决策。